Inivata Announces Collaboration with Maverick Therapeutics for use of RaDaR™ Assay
October 29, 2020 07:00 ET
|
Inivata
Inivata Announces Collaboration with Maverick Therapeutics for use of RaDaR™ Assay RaDaR ctDNA liquid biopsy test to be used to monitor patient response in Phase 1/2 study of MVC-101 in multiple...
Inivata Appoints Peter Collins as Chief Business Officer
September 22, 2020 07:00 ET
|
Inivata
Inivata Appoints Peter Collins as Chief Business Officer Research Triangle Park, NC, USA and Cambridge, UK, 22 September 2020 – Inivata, a leader in liquid biopsy, today announces the...
US Commercial Launch of InVisionFirst®-Lung
June 29, 2020 08:48 ET
|
Inivata
US Commercial Launch of InVisionFirst®-Lung Inivata’s Liquid Biopsy Test for Advanced Non-Small Cell Lung Cancer is Now Available Through NeoGenomics in the US Research Triangle Park, NC, USA and...
Inivata to Present Data at AACR Virtual Annual Meeting Highlighting Capabilities and Clinical Application of RaDaR™ Assay
June 22, 2020 09:32 ET
|
Inivata
Inivata to Present Data at AACR Virtual Annual Meeting Highlighting Capabilities and Clinical Application of RaDaR™ Assay Personalized assay for detection of residual disease and recurrence...
Inivata Joins Blood Profiling Atlas in Cancer (BloodPAC) Consortium
June 18, 2020 07:00 ET
|
Inivata
Inivata Joins Blood Profiling Atlas in Cancer (BloodPAC) Consortium Research Triangle Park, NC, USA and Cambridge, UK, 18 June 2020 - Inivata, a leader in liquid biopsy, announces that it has...
Inivata and Collaborators to Present New Data from the RaDaR™ Assay at AACR Virtual Annual Meeting II
June 04, 2020 07:00 ET
|
Inivata
Inivata and Collaborators to Present New Data from the RaDaR™ Assay at AACR Virtual Annual Meeting II Data will showcase capabilities of newly launched liquid biopsy assay for the detection of...
Inivata Announces Strategic Collaboration and Investment from NeoGenomics
May 26, 2020 05:06 ET
|
Inivata
Inivata Announces Strategic Collaboration and Investment from NeoGenomics NeoGenomics will commercialize Inivata’s InVisionFirst®-Lung liquid biopsy test in the United States Inivata and...
Inivata Offers Mobile Phlebotomy Services for patients undergoing InVisionFirst® Lung ctDNA liquid biopsy
May 12, 2020 07:00 ET
|
Inivata
Inivata Offers Mobile Phlebotomy Services for patients undergoing InVisionFirst® Lung ctDNA liquid biopsy Research Triangle Park, NC, USA May 12, 2020 – Inivata (www.inivata.com) a leader in...
Inivata Launches RaDaR™ Assay for Detection of Residual Disease and Recurrence
April 23, 2020 07:00 ET
|
Inivata
Inivata Launches RaDaR™ Assay for Detection of Residual Disease and Recurrence Personalized multi-tumor test provides potential new option for the rapid and sensitive identification of...
Inivata and the European Organisation for Research and Treatment of Cancer (EORTC) collaborate in Phase II NSCLC study
October 29, 2019 07:00 ET
|
Inivata
Inivata and the European Organisation for Research and Treatment of Cancer (EORTC) collaborate in Phase II NSCLC study Inivata to...